
: Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’
Pfizer’s experimental COVID-19 antiviral can cut the risk of ending up in the hospital or dying by 89%, and this means that Americans may soon have a choice in COVID-19 pills that they can take at home.
The news sent shares of Pfizer PFE soaring 8.2% in trading on Friday, capping off a week in which the company reported better-than-expected sales of its COVID-19 vaccine and shared that its oral COVID-19 pill had compelling results in a clinical trial.
“As…